Software isnt magical, its output is only as good as its input (and algorithms), you stated MYX will have about 50-60m NPAT for FY17, yet it had more than that in H1, so i think your make decisions based on bad input.
Its not too hard to research the US drug market, can search for Mayne at the following website to find approved drugs, and then search for product names to find competitors, has dates etc, so can see when new drugs come onto the market https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm
And you should not be advising people what to do (i.e. 'dont risk it'), its no-no on hotcopper, you should have stated that its your opinion that people not buy it, or that you wont buy it. Dont tell others what to do or people might consider you an advisor, which has legal risks.
MYX Price at posting:
94.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)